http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022260718-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_851a327d25463a2a5c46bc8268a21eaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fec8e43e5c5b32d0f831531787a9edf0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-07048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-686
filingDate 2022-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_847663665cf21a2ed3f690be59070f85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65a96fc5c2ca79bac100a3710324655b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dea345bcaf06bff8f556457f70f5422
publicationDate 2022-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022260718-A1
titleOfInvention Novel replicase cycling reaction (rcr)
abstract This invention generally relates to a novel RNA/mRNA production and amplification method using viral RNA replicase and/or RNA-dependent RNA polymerase (RdRp) enzymes as well as the associated mRNAs thereof. The present invention can be used for manufacturing and amplifying all varieties of RNA/mRNA sequences carrying at least an RdRp-binding site in the 5 '- or 3'-end, or both. The RNA/mRNA so obtained is useful for not only producing mRNA vaccines and/or RNA-based medicines but also for generating the mRNA-associated proteins, peptides, and/or antibodies under an in-vitro as well as in-cell translation condition. Principally, the present invention is a novel RNA replicase-mediated RNA/mRNA amplification method, namely Replicase Cycling Reaction (RCR). The RNA replicases involved in RCR include but not limited to viral and/or bacteriophage RNA-dependent RNA polymerases (RdRp), particularly coronaviral and hepatitis C viral (HCV) RdRp enzymes.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4219756-A1
priorityDate 2021-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6168943-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019330591-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02092774-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226445867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID425562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789

Total number of triples: 45.